Related Experiment Video

Updated: Aug 17, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

[Digitalis and sinus rhythm. An old question that is still current]

M Bobbio

    Giornale Italiano Di Cardiologia
    |March 1, 1986
    PubMed

    Insights

    Chronic digitalis therapy for heart failure in sinus rhythm shows questionable clinical benefit despite hemodynamic improvements. Withdrawing treatment may be possible for stable patients, but study limitations persist.

    Area of Science:

    • Cardiology
    • Pharmacology

    Background:

    • Congestive heart failure (CHF) management often involves digitalis.
    • The efficacy of digitalis in patients with CHF and normal sinus rhythm remains debated.

    Purpose of the Study:

    • To evaluate the effectiveness of long-term digitalis treatment in CHF patients with sinus rhythm.
    • To analyze clinical trials assessing digitalis therapy in this specific patient population.

    Main Methods:

    • Bibliographic search identifying 12 relevant clinical trials.
    • Clinical and methodological analysis of the selected studies.

    Main Results:

    • Discrepancy observed between digitalis's hemodynamic effects and clinical symptom improvement in CHF patients.
    • Many stable patients may tolerate discontinuation of chronic digitalis therapy without clinical decline.
    • Methodological limitations in studies affect the reliability of digitalis efficacy data.

    Conclusions:

    • The long-term efficacy of digitalis in CHF patients with sinus rhythm is controversial.
    • Findings suggest careful consideration for digitalis withdrawal in stable patients.
    • Lessons from digitalis controversy are crucial for evaluating new inotropic agents.

    More Related Videos

    Advanced Cardiac Rhythm Management by Applying Optogenetic Multi-Site Photostimulation in Murine Hearts08:43

    Advanced Cardiac Rhythm Management by Applying Optogenetic Multi-Site Photostimulation in Murine Hearts

    Published on: August 26, 2021

    Microelectrode Array Recording of Sinoatrial Node Firing Rate to Identify Intrinsic Cardiac Pacemaking Defects in Mice09:20

    Microelectrode Array Recording of Sinoatrial Node Firing Rate to Identify Intrinsic Cardiac Pacemaking Defects in Mice

    Published on: July 5, 2021

    Related Concept Videos

    Decreased pulse rate01:14

    Decreased pulse rate

    Bradycardia is a medical condition in which the heart rate is slower than normal. It occurs when the heart's natural pacemaker, the sinus node, generates slower electrical impulses than the standard rhythm. In adults, bradycardia is diagnosed when the pulse rate falls below 60 beats per minute, indicating a deviation from the normal heart rate range.
    There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with bradycardia...
    Electrophysiology of Normal Cardiac Rhythm01:19

    Electrophysiology of Normal Cardiac Rhythm

    The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase of...
    Heart Failure Drugs: Inotropic Agents01:26

    Heart Failure Drugs: Inotropic Agents

    Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
    ECG Interpretation of Arrhythmias I: Sinus Arrhythmias01:16

    ECG Interpretation of Arrhythmias I: Sinus Arrhythmias

    Arrhythmias are disturbances in the heart's rhythm that lead to abnormal heartbeats. These irregularities can originate from different parts of the heart and are classified based on their origin and nature.
    Types of Arrhythmias
    Sinus Node Arrhythmias
    Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism, and...
    Dysrhythmias VI: Management of Dysrhythmias01:25

    Dysrhythmias VI: Management of Dysrhythmias

    Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
    Cardiomyopathy II: Dilated Cardiomyopathy01:30

    Cardiomyopathy II: Dilated Cardiomyopathy

    Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...